Related Experiment Video
Updated: Aug 11, 2025
09:36
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
2.8K
Quantifying Critical Care Pharmacist Interventions in COVID-19.
Jack C Pluenneke1,2, Matthew W Semler2,3, Jonathan D Casey2,3
1Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, TN, USA.
Journal of Intensive Care Medicine
|February 9, 2023
Summary
Pharmacists provided significant medication management for critically ill coronavirus disease 2019 (COVID-19) patients, averaging 6 interventions per patient. Key interventions included medication discontinuation and ICU liberation bundle completion.
Area of Science:
- Critical Care Medicine
- Infectious Diseases
- Clinical Pharmacy
Background:
- The role of pharmacists in managing critically ill patients is established.
- Quantitative data on pharmacist interventions for coronavirus disease 2019 (COVID-19) patients are limited.
Purpose of the Study:
- To quantitatively describe pharmacist interventions in critically ill COVID-19 patients.
- To analyze the types and frequency of pharmacist interventions during the pandemic.
Main Methods:
- Retrospective observational study at a single center (Vanderbilt University Medical Center).
- Included adult patients admitted to the COVID-19 ICU or Medical ICU with a COVID-19 diagnosis (March 2020 - June 2021).
- Documented, categorized, and analyzed all pharmacist interventions.
Main Results:
- 768 patients analyzed; median age 63, 63% male, 71% Caucasian.
- Median hospital length of stay was 12 days, ICU length of stay was 5 days.
- Pharmacists performed 7027 interventions for 655 patients (median 6 interventions/patient).
- Top interventions: medication discontinuation (24%), ICU liberation bundle (19%), dose adjustment (18%).
Conclusions:
- Pharmacists actively managed medications for critically ill COVID-19 patients.
- Findings highlight the expanding role of clinical pharmacists in critical care during pandemics.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
19
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
19
01:27Coronary Artery Disease V: Interprofessional Care
21
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
21
01:26Acute Coronary Syndrome V: Nursing Management
23
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
23
01:26Standard Precaution
2.1K
Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.1K
01:22Healthcare Associated Infections II: Preventive Measures
2.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.7K
01:28Pneumonia IV: Management
412
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
412